rs73066479

Positions:

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.1360G>A variant in IDUA is a missense variant predicted to cause substitution of valine by isoleucine at amino acid 454 (p.Val454Ile). The highest population minor allele frequency in gnomAD v4.1.0 is 0.3004 (19925/66322 alleles; 3158 homozygotes; Grpmax Filtering AF 95% confidence = 0.2969) in the South Asian population, which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for BA1 (>0.005), and therefore meets this criterion (BA1). There is a ClinVar entry for this variant (Variation ID: 92630). In summary, this variant meets the criteria to be classified as benign for mucopolysaccharidosis type 1. IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): BA1.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 6, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA145872/MONDO:0001586/091

Frequency

Genomes: 𝑓 0.17 ( 2366 hom., cov: 33)
Exomes 𝑓: 0.16 ( 17534 hom. )

Consequence

IDUA
NM_000203.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 1.15
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IDUANM_000203.5 linkuse as main transcriptc.1360G>A p.Val454Ile missense_variant 9/14 ENST00000514224.2 NP_000194.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IDUAENST00000514224.2 linkuse as main transcriptc.1360G>A p.Val454Ile missense_variant 9/142 NM_000203.5 ENSP00000425081 P1P35475-1

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26206
AN:
151822
Hom.:
2370
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.213
Gnomad AMI
AF:
0.171
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.166
Gnomad EAS
AF:
0.201
Gnomad SAS
AF:
0.300
Gnomad FIN
AF:
0.144
Gnomad MID
AF:
0.236
Gnomad NFE
AF:
0.152
Gnomad OTH
AF:
0.183
GnomAD3 exomes
AF:
0.203
AC:
7144
AN:
35220
Hom.:
867
AF XY:
0.219
AC XY:
4701
AN XY:
21452
show subpopulations
Gnomad AFR exome
AF:
0.247
Gnomad AMR exome
AF:
0.0791
Gnomad ASJ exome
AF:
0.195
Gnomad EAS exome
AF:
0.255
Gnomad SAS exome
AF:
0.322
Gnomad FIN exome
AF:
0.169
Gnomad NFE exome
AF:
0.183
Gnomad OTH exome
AF:
0.203
GnomAD4 exome
AF:
0.161
AC:
202361
AN:
1256844
Hom.:
17534
Cov.:
37
AF XY:
0.164
AC XY:
101139
AN XY:
615192
show subpopulations
Gnomad4 AFR exome
AF:
0.222
Gnomad4 AMR exome
AF:
0.0948
Gnomad4 ASJ exome
AF:
0.164
Gnomad4 EAS exome
AF:
0.158
Gnomad4 SAS exome
AF:
0.301
Gnomad4 FIN exome
AF:
0.159
Gnomad4 NFE exome
AF:
0.152
Gnomad4 OTH exome
AF:
0.169
GnomAD4 genome
AF:
0.172
AC:
26203
AN:
151930
Hom.:
2366
Cov.:
33
AF XY:
0.173
AC XY:
12841
AN XY:
74290
show subpopulations
Gnomad4 AFR
AF:
0.212
Gnomad4 AMR
AF:
0.124
Gnomad4 ASJ
AF:
0.166
Gnomad4 EAS
AF:
0.201
Gnomad4 SAS
AF:
0.299
Gnomad4 FIN
AF:
0.144
Gnomad4 NFE
AF:
0.152
Gnomad4 OTH
AF:
0.182
Alfa
AF:
0.151
Hom.:
237
Bravo
AF:
0.170
TwinsUK
AF:
0.166
AC:
614
ALSPAC
AF:
0.159
AC:
614
ExAC
AF:
0.114
AC:
3158
Asia WGS
AF:
0.250
AC:
869
AN:
3462

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 02, 2017- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not provided Benign:4
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 29, 2018This variant is associated with the following publications: (PMID: 12509712, 28649516) -
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicFeb 27, 2017- -
Mucopolysaccharidosis type 1 Benign:3
Benign, no assertion criteria providedclinical testingNatera, Inc.May 11, 2017- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Mucopolysaccharidosis, MPS-I-H/S Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Mucopolysaccharidosis, MPS-I-S Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Hurler syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
3.8
DANN
Benign
0.47
DEOGEN2
Uncertain
0.47
T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.62
T;.
MetaRNN
Benign
0.0035
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.85
L;.
MutationTaster
Benign
1.0
P;P;P
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.17
N;N
REVEL
Benign
0.094
Sift
Benign
0.81
T;T
Sift4G
Benign
0.41
T;T
Polyphen
0.0070
B;.
Vest4
0.016
MPC
0.16
ClinPred
0.0022
T
GERP RS
0.14
Varity_R
0.13
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73066479; hg19: chr4-996690; API